Male breast cancer: Patient and surgeon experiences
Full article: https://link.springer.com/article/10.1245/s10434-022-12135-6
By surveying male breast cancer patients and the surgeons who treat them, researchers gained insight into the experiences of both groups, shedding light on an important issue for men with breast cancer. (Posted 12/22/22)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- Is lumpectomy or partial mastectomy an option for me?
- How can I get genetic testing?
- What are the pros and cons of a lumpectomy vs a single or double mastectomy?
- What are my options for reconstruction? Is it covered by my insurance?
Open Clinical Trials
The following organizations have resources related to breast cancer.
- FORCE related resources:
- General breast cancer resources:
- Metastatic breast cancer resources:
- Male breast cancer resources:
- Resources for Black, Indigenous and People of Color:
The National Comprehensive Cancer Network (NCCN) has a panel of experts who address male breast cancer in their breast cancer treatment guidelines.
- The NCCN panel points out that few clinical trials have focused on men with breast cancer, and treatment recommendations for men are taken from findings from research involving only women. Therefore, many of the recommendations for the treatment of male breast cancer are similar to treatment in women, including:
- sentinel lymph node biopsy
- radiation therapy
- Oncotype Dx
- systemic therapy
- The panel highlights the following considerations for male breast cancer:
- All men with breast cancer should be referred for genetic counseling and testing.
- Although men with breast cancer were previously recommended to undergo mastectomy, emerging data suggest that breast-conservation therapy for men may be as safe and effective as mastectomy.
For ER receptor-positive cancers, hormone therapy options include tamoxifen or a GnRH analog plus an aromatase inhibitor. Aromatase inhibitors used alone (without a GnRH analog medication) have resulted in worse outcomes than tamoxifen alone in men. Men who receive GnRH analogs and aromatase inhibitors should have their bone density checked.
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.